Baxter International Inc. (NYSE:BAX) Shares Sold by RNC Capital Management LLC

RNC Capital Management LLC decreased its holdings in shares of Baxter International Inc. (NYSE:BAX) by 34.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 78,193 shares of the medical instruments supplier’s stock after selling 41,359 shares during the quarter. RNC Capital Management LLC’s holdings in Baxter International were worth $2,280,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. First PREMIER Bank acquired a new stake in Baxter International during the third quarter worth about $25,000. Fortitude Family Office LLC acquired a new stake in shares of Baxter International in the third quarter valued at approximately $38,000. LRI Investments LLC increased its stake in shares of Baxter International by 60.8% in the third quarter. LRI Investments LLC now owns 1,560 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 590 shares during the period. Cromwell Holdings LLC acquired a new stake in shares of Baxter International in the third quarter valued at approximately $62,000. Finally, CKW Financial Group increased its stake in shares of Baxter International by 100.0% in the third quarter. CKW Financial Group now owns 2,200 shares of the medical instruments supplier’s stock valued at $81,000 after purchasing an additional 1,100 shares during the period. Institutional investors and hedge funds own 90.19% of the company’s stock.

Wall Street Analyst Weigh In

BAX has been the topic of several analyst reports. Citigroup dropped their price target on shares of Baxter International from $37.00 to $35.00 and set a “neutral” rating on the stock in a research note on Wednesday, December 11th. Stifel Nicolaus dropped their price target on shares of Baxter International from $46.00 to $38.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Finally, StockNews.com lowered shares of Baxter International from a “buy” rating to a “hold” rating in a research note on Monday, November 11th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Baxter International presently has a consensus rating of “Hold” and a consensus target price of $40.90.

Baxter International Trading Down 2.0 %

Baxter International stock opened at $30.84 on Friday. The company has a 50 day moving average price of $30.87 and a 200 day moving average price of $34.48. Baxter International Inc. has a 52 week low of $28.33 and a 52 week high of $44.01. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.09 and a current ratio of 1.43. The firm has a market capitalization of $15.74 billion, a price-to-earnings ratio of 154.18, a P/E/G ratio of 10.39 and a beta of 0.61.

Baxter International (NYSE:BAX) last posted its quarterly earnings data on Friday, November 8th. The medical instruments supplier reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.02. The firm had revenue of $3.85 billion during the quarter, compared to analyst estimates of $3.85 billion. Baxter International had a net margin of 0.77% and a return on equity of 18.30%. The company’s revenue was up 3.8% on a year-over-year basis. During the same quarter last year, the business posted $0.68 EPS. Research analysts forecast that Baxter International Inc. will post 1.83 EPS for the current year.

Baxter International Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th were paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 2.21%. The ex-dividend date was Friday, November 29th. Baxter International’s dividend payout ratio (DPR) is currently 340.02%.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.